Exosome Therapy at Rebuild Regen: DayZero™ Vials From 150 Billion to 500 Billion Particles

Exosome therapy is a regenerative medicine treatment that uses extracellular vesicles — nanoscale signaling particles derived from perinatal tissue — to deliver repair-triggering biological signals directly to target tissues.

Exosomes are not cells. They do not grow, divide, or engraft. Exosome therapy works by delivering a precise molecular payload that instructs adjacent cells to shift from an inflammatory state to a repair state. This signaling function makes exosome therapy one of the more precise delivery mechanisms in regenerative medicine, and the clinical science behind exosomes has expanded considerably in the past decade.

At Rebuild Regen Medical Clinic, exosome therapy uses DayZero™ extracellular vesicles from ZEO ScientifiX — a perinatal tissue supplier with AABB accreditation, FDA-registered cGMP manufacturing, and ISO-7 cleanroom processing. Particle counts in the therapeutic line range from 150 billion to 500 billion per vial. Aesthetic applications use lower-concentration vials between 25 billion and 100 billion particles. The right concentration depends on the indication, delivery method, and clinical picture established during consultation with Elizabeth Celestin, APRN, FNP-C.

What Exosomes Are — EVs, Not Cells

Exosomes are the smallest category of extracellular vesicles (EVs) — membrane-bound particles released by cells as part of normal intercellular communication. Exosomes typically range from 30 to 150 nanometers in diameter, small enough to cross biological barriers that larger particles cannot.

Exosomes carry a repair-triggering cargo payload — molecular instructions derived from the parent cell. When exosome therapy delivers these particles from a young perinatal source to a site of injury or inflammation, the exosomes bring those instructions directly into the local cellular environment. Recipient cells respond to the exosome-carried signals by modulating inflammatory cascades and shifting toward a repair state.

Exosome therapy is described as "cell-free biologic" therapy because the therapeutic effect does not depend on the introduction of living cells or engraftment into tissue. Exosome therapy works informationally: exosome-delivered molecular signals activate the body's existing cellular machinery to execute the repair response.

DayZero™ exosomes are derived from perinatal tissue (Wharton's jelly of the umbilical cord) — a source that produces exosomes with a potent anti-inflammatory and regenerative signaling profile that is less present in exosomes derived from older tissue sources.

DayZero™ Exosome Line — Particle Counts and Applications

ZEO ScientifiX produces the DayZero™ exosome line in multiple concentrations to match clinical indication:

Therapeutic vials:

150 billion particles — standard single-site orthopedic injection, localized inflammatory conditions
250 billion particles — multi-joint orthopedic protocols, more complex inflammatory presentations
500 billion particles — IV administration, systemic anti-aging, neuroinflammation, post-COVID recovery support, complex systemic presentations

Aesthetic vials:

25B to 100B particles — scalp injections for hair restoration, microneedling adjunct for skin rejuvenation, topical application in aesthetic procedures

Every lot is tested and accompanied by a Certificate of Analysis confirming particle count, sterility, and identity. The product lineage from donor tissue to labeled vial is fully documented. No batch ships without a passing COA.

Elizabeth selects the appropriate concentration and delivery method based on your clinical goals, the site being treated, and whether you're combining exosome therapy with stem cells, PRP, or other modalities. The products are complementary and often used together for synergistic effect.

Conditions — Neuroinflammation, Orthopedic, Aesthetic, Systemic Anti-Aging

Exosome therapy at Rebuild Regen is applied across four broad clinical categories:

Neuroinflammation and neuropathic conditions: Exosome therapy for neuroinflammation delivers neuroprotective signals particularly relevant to conditions including peripheral neuropathy, diabetic neuropathy, and post-COVID neurological symptoms. In neuropathy cases, exosome therapy is often integrated into The Rebuild Neuropathy Protocol™ alongside Class IV laser therapy and IV nutritional support.

Orthopedic and musculoskeletal: Exosome therapy for knee, shoulder, hip, and spine conditions targets the inflammatory and degenerative components of these injuries. Exosome therapy delivers anti-inflammatory signals directly to the site of tissue damage, used independently or in combination with stem cell therapy or PRP to create a layered biological response that can break the chronic inflammation cycle impeding natural tissue healing.

Aesthetic applications: Exosome therapy for scalp injection targets hair loss conditions, particularly androgenetic alopecia. Exosome therapy via microneedling supports skin rejuvenation through cellular turnover, collagen synthesis, and follicle signaling that conventional topical products cannot achieve.

Systemic anti-aging and recovery: Exosome therapy via high-dose IV administration targets systemic inflammatory burden, mitochondrial function, immune regulation, and post-illness recovery. These exosome therapy protocols are typically combined with NAD+ infusion or stem cell therapy for patients with complex systemic presentations.

As with all biologic therapies at this clinic, the clinical indication drives the protocol. Exosome therapy is not positioned as a universal remedy — it is a specific signaling intervention with defined mechanisms and appropriate patient profiles.

Administration — Local Injection vs. IV, What the Session Looks Like

Exosome therapy at Rebuild Regen is administered via two primary routes depending on the indication:

Local injection: The exosome preparation is injected directly into the target joint, soft tissue, or anatomical site. For orthopedic conditions, this is the standard delivery route. The injection itself takes a few minutes; the overall session including preparation and post-procedure observation runs 30 to 45 minutes. Patients typically return to normal activity within 24 hours.

Intravenous (IV) administration: For systemic anti-aging, neurological, or high-load presentations, exosomes are delivered via IV infusion. Session duration runs 60 to 90 minutes. The IV route allows circulating exosomes to reach multiple tissue sites and cross the blood-brain barrier, which is relevant for neuroinflammatory applications.

Scalp and aesthetic delivery: For hair restoration, exosomes are injected into the scalp at targeted follicle zones. For skin rejuvenation, they are applied topically or via microneedling as part of an aesthetic session.

Elizabeth designs the session plan during the consultation appointment. For patients combining exosome therapy with stem cells or PRP, the biologics may be administered in sequence or simultaneously at the same treatment visit, depending on the protocol design.

Exosome Therapy or Stem Cell Therapy: Which Fits Your Situation?

The distinction between exosome therapy and stem cell therapy is one of the most common questions at this practice, and the answer depends on your clinical picture rather than a general ranking of one over the other.

Stem cells are living cells that secrete exosomes as part of their mechanism — among other paracrine signals. Choosing stem cells means introducing a cellular source that actively produces signaling molecules in situ, with a more sustained paracrine effect over time. Choosing exosomes means delivering a specific molecular payload directly, without introducing living cells, which can be preferable for patients with contraindications to cellular therapy or for aesthetic applications where precision delivery matters more than cellular persistence.

For many patients, the most effective approach is a combination: stem cells for foundational MSC signaling, exosomes layered on top for enhanced micro-RNA delivery and targeted anti-inflammatory effect. This is a common protocol design at Rebuild Regen for complex orthopedic and neurological presentations.

The right answer comes from the consultation, not from a product comparison chart.

Frequently Asked Questions

What are exosomes exactly?

Exosomes are extracellular vesicles — nanoscale membrane-bound particles released by cells that carry biological signaling molecules between cells. DayZero™ exosomes used at this clinic come from perinatal tissue and carry a signaling payload that supports anti-inflammatory and repair responses in recipient tissues.

How are exosomes different from stem cells?

Exosomes are not cells. They do not grow, divide, or engraft. Stem cells are living cells that release exosomes (among other paracrine signals) as their primary therapeutic mechanism. Exosome therapy delivers that molecular cargo directly without introducing living cells. Some patients and indications are better suited to one approach; many benefit from combining both.

How many exosome particles are needed?

The right particle count depends on the clinical indication and delivery route. Localized orthopedic injections typically use 150B to 250B particle vials. Systemic IV protocols use 500B vials. Aesthetic applications use 25B to 100B. Elizabeth selects the concentration based on your specific clinical picture during consultation.

Are exosomes FDA-approved?

DayZero™ exosomes are manufactured in an FDA-registered, cGMP, AABB-accredited facility under 21 CFR Part 1271. The product is manufactured under full regulatory compliance. Exosome therapy as a treatment modality does not have specific FDA approval for individual conditions. This is a consistent disclosure across all biologic therapies at this clinic.

How many sessions are recommended?

The number of sessions depends on the condition and the patient's response. Some conditions respond to a single treatment. Others benefit from a series of two or three sessions. Post-treatment follow-up at 4 to 6 weeks guides any additional recommendations.

Can exosome therapy help with hair loss?

Scalp exosome injection targets follicle-level signaling, particularly for androgenetic alopecia and diffuse thinning. The growth factors and micro-RNA in perinatal exosomes support follicle activity and cellular turnover in ways that topical products do not reach. Results vary by degree of hair loss; early to moderate thinning responds better than end-stage follicle loss.

When Exosome Therapy Is Not the First Choice

Exosome therapy is not a first-line treatment for conditions with a clear surgical indication (severe structural failure requiring reconstruction), conditions where root cause diagnosis has not been established, or late-stage degenerative presentations where biological repair capacity has been exhausted. It is also not appropriate in the presence of active infection, active malignancy, or pregnancy. For patients whose primary condition is mechanical rather than inflammatory, other interventions (decompression, physical therapy, shockwave) may produce better outcomes as a starting point. Elizabeth addresses this assessment directly during the consultation.

Rebuild Regen Medical Clinic 3320 N Federal Hwy #101, Lighthouse Point, FL 33064 (954) 953-4208 | rebuildregenmedical.com

Schedule a Consultation | Compare: Stem Cell vs Exosome Therapy